Physician profile
Andrew D Brown
NPI 1568825677
$6,294.75
in general payments reported to CMS, 2019-2025
36 companies · $2,257 in 2025
The $2,257 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.23 · 2020: $57.57 · 2021: $802 · 2022: $866 · 2023: $1,150 · 2024: $1,149 · 2025: $2,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,556.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $837.10 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $766.68 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $713.81 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $578.63 | 2021-2025 | Wainua, Farxiga |
| Abiomed | $366.51 | 2023-2025 | Impella |
| Merck Sharp & Dohme LLC | $296.17 | 2022-2025 | Verquvo |
| Medtronic, INC. | $266.75 | 2022-2025 | Endurant Iis, Linq II |
| Irhythm Technologies, INC. | $240.38 | 2022-2023 | Zio Xt Patch |
| Philips North America LLC | $221.93 | 2024-2025 | (Bh4) Igt Devices Undivided, Lm Undivided, (6571) Eagle Eye |
| Boston Scientific Corporation | $210.31 | 2022-2025 | Cds - Mct/Cem Monitoring, Patientcare Link |
| Alnylam Pharmaceuticals INC. | $210.22 | 2024-2025 | Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $154.23 | 2021-2025 | Eliquis, Camzyos |
| Novo Nordisk INC | $141.04 | 2024-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $120.14 | 2022-2025 | |
| Idorsia Pharmaceuticals US INC | $108.16 | 2025 | Tryvio |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.